Discover the Magical Herb That Fights Stress and Boosts Your Memory
Ashwagandha, also known as Indian ginseng or Withania somnifera, is one of the most renowned medicinal herbs in traditional Indian medicine (Ayurveda), used for thousands of years. It is classified as an adaptogenic herb, meaning it helps the body adapt to physical and mental stress.
Recent studies have shown that Ashwagandha may lower cortisol levels, the stress hormone, making it a natural option for reducing anxiety and promoting calm. Research also suggests it can improve sleep quality, combat insomnia, and boost physical energy and stamina.
Ashwagandha has also shown promise in enhancing cognitive functions and memory, thanks to its antioxidant properties that may support brain and immune health. Hormonally, it may help increase testosterone and fertility in men, and support hormonal balance and menstrual regulation in women.
Despite its many benefits, experts caution that it may not be suitable for everyone. Pregnant women, breastfeeding mothers, and individuals with thyroid conditions are advised to avoid it due to potential hormonal effects. It may also interact with sedatives, blood pressure medications, or diabetes drugs, and could cause side effects like drowsiness, headache, digestive issues, or low blood pressure.
Ashwagandha is available in various forms, including capsules, powder, tea, and liquid extract, with common doses ranging between 300 to 600 mg daily of high-concentration extract. Always consult a doctor or herbal specialist before starting use.
read more
15 Ludicrous Cosplay Costumes That Will Blow You Away
Watch... Dorra's natural beauty will blow your mind in latest photo session
Exercising For As Little As 150 Minutes A Week Will Make You Happier، Study Claims
ARIES: Your Horoscope for April 7
FDA Now Considers Vaping A Rising Epidemic In High School
Lifestyle
How to make Dried salted fish (feseekh) -By Chef El-Sherbini
Lifestyle
Batarekh Dip & Sardine Dip
Lifestyle
Best of Easter cookie and cakes
Lifestyle
ARIES friendship
News
Israeli-Linked Hadassah Clinic in Moscow Treats Wounded Iranian IRGC Fighters
Arts & Culture
"Jurassic World Rebirth" Gets Streaming Date
News
China Launches Largest Ever Aircraft Carrier
Videos & Features
Tragedy Overshadows MC Alger Championship Celebration: One Fan Dead, 11 Injured After Stadium Fall
Lifestyle
Get to Know 2025 Eid Al Adha Prayer Times in Egypt
Arts & Culture
South Korean Actress Kang Seo-ha Dies at 31 after Cancer Battle
Business
Egyptian Pound Undervalued by 30%, Says Goldman Sachs
Sports
Get to Know 2025 WWE Evolution Results
News
"Tensions Escalate: Iran Probes Allegations of Indian Tech Collaboration with Israeli Intelligence"
News
Flights suspended at Port Sudan Airport after Drone Attacks
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
See - Sada Elbalad
2 days ago
- See - Sada Elbalad
Discover the Magical Herb That Fights Stress and Boosts Your Memory
Pasant Elzaitony Ashwagandha, also known as Indian ginseng or Withania somnifera, is one of the most renowned medicinal herbs in traditional Indian medicine (Ayurveda), used for thousands of years. It is classified as an adaptogenic herb, meaning it helps the body adapt to physical and mental stress. Recent studies have shown that Ashwagandha may lower cortisol levels, the stress hormone, making it a natural option for reducing anxiety and promoting calm. Research also suggests it can improve sleep quality, combat insomnia, and boost physical energy and stamina. Ashwagandha has also shown promise in enhancing cognitive functions and memory, thanks to its antioxidant properties that may support brain and immune health. Hormonally, it may help increase testosterone and fertility in men, and support hormonal balance and menstrual regulation in women. Despite its many benefits, experts caution that it may not be suitable for everyone. Pregnant women, breastfeeding mothers, and individuals with thyroid conditions are advised to avoid it due to potential hormonal effects. It may also interact with sedatives, blood pressure medications, or diabetes drugs, and could cause side effects like drowsiness, headache, digestive issues, or low blood pressure. Ashwagandha is available in various forms, including capsules, powder, tea, and liquid extract, with common doses ranging between 300 to 600 mg daily of high-concentration extract. Always consult a doctor or herbal specialist before starting use. read more 15 Ludicrous Cosplay Costumes That Will Blow You Away Watch... Dorra's natural beauty will blow your mind in latest photo session Exercising For As Little As 150 Minutes A Week Will Make You Happier، Study Claims ARIES: Your Horoscope for April 7 FDA Now Considers Vaping A Rising Epidemic In High School Lifestyle How to make Dried salted fish (feseekh) -By Chef El-Sherbini Lifestyle Batarekh Dip & Sardine Dip Lifestyle Best of Easter cookie and cakes Lifestyle ARIES friendship News Israeli-Linked Hadassah Clinic in Moscow Treats Wounded Iranian IRGC Fighters Arts & Culture "Jurassic World Rebirth" Gets Streaming Date News China Launches Largest Ever Aircraft Carrier Videos & Features Tragedy Overshadows MC Alger Championship Celebration: One Fan Dead, 11 Injured After Stadium Fall Lifestyle Get to Know 2025 Eid Al Adha Prayer Times in Egypt Arts & Culture South Korean Actress Kang Seo-ha Dies at 31 after Cancer Battle Business Egyptian Pound Undervalued by 30%, Says Goldman Sachs Sports Get to Know 2025 WWE Evolution Results News "Tensions Escalate: Iran Probes Allegations of Indian Tech Collaboration with Israeli Intelligence" News Flights suspended at Port Sudan Airport after Drone Attacks
Daily News Egypt
3 days ago
- Daily News Egypt
Egyptian Drug Authority discusses plans for joint pharmaceutical plant in Zambia
Ali El-Ghamrawi, head of the Egyptian Drug Authority, held talks with a joint delegation from Egyptian firm Wadi El-Nile and Zambian developer Pendulum Estates Ltd as part of Egypt's strategy to expand into African markets and strengthen international pharmaceutical partnerships. Discussions centred on plans to establish a joint drug manufacturing plant in Zambia. The initiative aligns with Egypt's broader vision to deepen industrial integration across Africa, transfer expertise and technology, boost regional production capacity, encourage pharmaceutical investment, and enhance regulatory cooperation with African counterparts. It also aims to reinforce Egypt's position as a regional pharmaceutical hub and contribute to securing medicine supplies across the continent. During the meeting, El-Ghamrawi highlighted that localising pharmaceutical production in African countries remains a strategic priority for the Authority. He described the African market as a key target for Egyptian pharmaceutical expansion, both to improve access to essential medicines and support local industry development. Mohamed Dabour, Chairperson of Wadi El-Nile, emphasised the importance of the partnership with the Zambian side, describing the project as a major milestone in the company's plans to expand across Africa and help localise pharmaceutical production on a continental scale. John Zulu, Chairperson of Pendulum Estates Ltd, welcomed the cooperation with Egypt and described the partnership as transformative for Zambia's healthcare system, enabling the domestic production of high-quality medicines to meet local demand. The delegation praised the Drug Authority's strategic leadership and its advanced regulatory and technical expertise, which they said has helped elevate Egypt's pharmaceutical sector both regionally and internationally. They noted that collaboration with the Authority would provide vital technical support, advisory services, and regulatory facilitation needed for the success of the proposed joint plant in Zambia — ultimately enhancing access to quality medicines and supporting health security across Africa. The partnership reflects the Drug Authority's commitment to fostering deeper cooperation with African nations and backing pharmaceutical investments that promote industry growth and deliver tangible health benefits across the continent.
Al-Ahram Weekly
4 days ago
- Al-Ahram Weekly
Experts to revise hormone replacement therapy warnings - Health - Life & Style
US Food and Drug Administration Commissioner Marty Makary signaled that he is open to revising strict warning labels on Hormone Replacement Therapy, following testimony from experts who said the treatment's risks have long been exaggerated. HRT is taken to replace estrogen the body stops producing after menopause -- when periods end permanently -- and helps relieve symptoms such as hot flashes, vaginal discomfort, and pain during sex. But its use has plummeted in recent years amid concerns including a possible link to invasive breast cancer. Food and Drug Administration (FDA) chief Marty Makary, who convened Thursday's meeting of outside experts, told AFP: "We have to revisit these topics." He argued that the framework that led to so-called "black box warnings" -- the strongest warning the FDA can require for prescription drugs -- "came from a different era." "Not only is there no clinical trial showing an increase in breast cancer mortality, but there are also other tremendous long term health benefits," Makary added. The 12 experts convened by the agency said HRT's benefits go beyond easing menopausal symptoms. They cited evidence for reduced fracture risk, improved cardiovascular and cognitive health, and fewer urinary tract infections. "Estrogen is the only well-established intervention to reduce the frequency of osteoporotic fracture in postmenopausal women, to the tune of 30 to 50 percent," said Vonda Wright, an orthopedic surgeon at the University of Central Florida. Roberta Diaz Brinton, director of the Center for Innovation in Brain Science, said her research suggests the reason two-thirds of people globally with Alzheimer's are women is not because they live slightly longer than men, but because the disease begins during the menopausal transition. "Depending upon when hormone therapy is introduced... there's a significant reduction in risk of developing Alzheimer's disease," she said. The University of Arizona researcher linked menopause to a drop in the brain's ability to metabolize glucose and a rise in protein plaque deposits. Panelists blamed the collapse in HRT use on the Women's Health Initiative (WHI), a landmark clinical trial halted in 2002 after flagging a possible increased breast cancer risk -- findings they say were misinterpreted. "Prescriptions for hormone replacement therapy plummeted in the United States, women flushed their pills down the toilet," Makary said in his opening remarks, mentioning his own mother's experience of multiple bone fractures in old age. Critics of the WHI argue it included participants well past menopause -- when risks are higher and benefits lower -- and used outdated formulations no longer common today. Still, the issue remains divisive within the medical community. HRT can be administered through various means including orally, through skin patches, or vaginally; and is given either as estrogen alone or with progesterone. The FDA's own warning label for it cites risks including endometrial cancer, breast cancer, and life-threatening blood clots. Adriane Fugh-Berman, who directs a project that promotes rational prescribing at Georgetown University, attended as an observer and criticized the lack of dissenting voices. "This was a very one-sided panel of people who are all proponents of hormone therapy and who seem to have a very poor understanding of the evidence," she told AFP. "While hormones can be a useful treatment for severe menopausal symptoms, they should not be used for chronic disease prevention," she added, noting that no randomized clinical trial -- the gold standard of evidence -- has found HRT beneficial for cognition or dementia prevention. She also said that after the WHI findings were released, hormone use fell globally -- and breast cancer rates dropped across registries tracking them. Several of the panelists had ties to companies offering menopause treatments or are affiliated with the advocacy group "Let's Talk Menopause," which receives pharmaceutical funding and campaigns to revise FDA warning labels. Follow us on: Facebook Instagram Whatsapp Short link:
